{"altmetric_id":4696473,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Celgene Corporation"],"first_seen_on":"2015-10-28T16:58:55+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1379752400,"links":["http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01947309?term=cancer&recr=Open&no_unk=Y&lup_s=09\/07\/2013&lup_d=14&show_rss=Y&sel_rss=mod14"],"nct_id":"NCT01947309","pubdate":"2013-09-18T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4437222,"mean":4.8070320978109,"rank":3437109,"this_scored_higher_than_pct":2,"this_scored_higher_than":130536,"rank_type":"exact","sample_size":4437222,"percentile":2},"similar_age_3m":{"total_number_of_other_articles":76756,"mean":5.384022643476,"rank":47336,"this_scored_higher_than_pct":1,"this_scored_higher_than":1403,"rank_type":"exact","sample_size":76756,"percentile":1},"this_journal":{"total_number_of_other_articles":9838,"mean":2.7971391684457,"rank":7000,"this_scored_higher_than_pct":2,"this_scored_higher_than":274,"rank_type":"exact","sample_size":9838,"percentile":2},"similar_age_this_journal_3m":{"total_number_of_other_articles":240,"mean":1.5602510460251,"rank":142,"this_scored_higher_than_pct":1,"this_scored_higher_than":1,"rank_type":"exact","sample_size":240,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}},"geo":{"twitter":{"US":1}}},"counts":{"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["GoToPER"],"posts_count":1}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/GoToPER\/status\/381335323596189696","license":"public","citation_ids":[4696473],"posted_on":"2013-09-21T08:33:20+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"381335323596189696"}]}}